Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women

BACKGROUND: Estimates of the humoral immune response to incident human papillomavirus (HPV) infections are limited. METHODS: In this post hoc analysis of 3875 women aged 16–23 years from a 4-valent HPV vaccine trial (NCT00092482), HPV seroprevalence on day 1 was measured with a 9-valent HPV (HPV 6/1...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Darron R., Castellsagué, Xavier, Ferris, Daron, Garland, Suzanne M., Huh, Warner, Steben, Marc, Wheeler, Cosette M., Saah, Alfred, Luxembourg, Alain, Li, Se, Velicer, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172167/
https://www.ncbi.nlm.nih.gov/pubmed/35525430
http://dx.doi.org/10.1016/j.tvr.2022.200236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172167/
https://www.ncbi.nlm.nih.gov/pubmed/35525430
http://dx.doi.org/10.1016/j.tvr.2022.200236

Ejemplares similares